LAVA Therapeutics N.V.
LVTX · NASDAQ
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
LAVA Therapeutics N.V. (LVTX) is a biopharmaceutical company specializing in the development of novel immunotherapeutic drugs. The company focuses on developing therapies that harness the natural abilities of the immune system to combat cancer and other diseases. LAVA Therapeutics focuses on researching and developing new treatment approaches, utilizing immune system-based technologies such as immune modulators and specific antigens. The company responds to the growing interest in new forms of cancer therapy and treatments based on the immune system. Shares of LAVA Therapeutics N.V. (LVTX) can be an interesting choice for investors tracking the biopharmaceutical and research sector.
Sector
Healthcare
Industry
Biotechnology
CEO
Stephen Allen Hurly
Employees
34
Headquarters
Utrecht